The US Food and Drug Administration (FDA) has approved nemolizumab for moderate-to-severe atopic dermatitis inadequately ...

When managing complex chronic dermatologic diseases, efforts to incorporate alternative treatments can add efficacy, patient ...

Paxneury and Tuzulby should be granted Europe-wide marketing authorizations for treating attention-deficit hyperactivity, the ...

The European Medicines Agency (EMA) has given a positive recommendation for Rytelo ( imetelstat) for the treatment of adult ...

The different associations of standing hypertension and systolic orthostatic increases in BP with CVD raises concerns about ...

Oral doxycycline may be as effective as IV penicillin in treating ocular syphilis for some patients with the condition, a new ...

A new study analyzes the rise in e-scooter and e-bike injuries since 2019 and the impact of alcohol and substance abuse on ...

A case series showed that chimeric antigen receptor T-cell therapy targeting CD19 halted the progression of fibrotic organ ...

Europe’s medicines regulator has backed a pediatric indication for Ofev to treat progressive fibrosing interstitial lung ...

Results of the INSEMA trial indicated that it’s safe to omit axillary sentinel lymph node biopsy in patients with clinically ...

Incorporating NT-proBNP, a biomarker for heart failure, into traditional risk prediction models for AF may enhance early ...

In a multicohort study, abdominal pain was found to be common in patients with ulcerative colitis, regardless of whether they ...